Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments: Baseline results of the REDEEM trial.
Saved in:
| Title: | Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments: Baseline results of the REDEEM trial. |
|---|---|
| Authors: | Wong J; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia; Royal Melbourne Hospital, Melbourne, Australia., Smith J; Baker Heart and Diabetes Institute, Melbourne, Australia., Soh CH; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia., Howden E; Baker Heart and Diabetes Institute, Melbourne, Australia., Talbot JS; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia., Nolan M; Baker Heart and Diabetes Institute, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia., Whitmore K; Menzies Institute for Medical Research, Hobart, Tasmania, Australia., Wright L; Baker Heart and Diabetes Institute, Melbourne, Australia., Sherriff AG; Baker Heart and Diabetes Institute, Melbourne, Australia., Sivaraj E; Menzies Institute for Medical Research, Hobart, Tasmania, Australia., Wheeler G; Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Wiltshire K; Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Campbell P; Barwon Health, Geelong, Australia., Ramkumar S; Victorian Heart Hospital, Melbourne, Australia., Tam C; Alfred Health, Melbourne, Australia., Marwick TH; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia; Menzies Institute for Medical Research, Hobart, Tasmania, Australia. Electronic address: tom.marwick@baker.edu.au. |
| Source: | American heart journal [Am Heart J] 2026 Feb; Vol. 292, pp. 107277. Date of Electronic Publication: 2025 Sep 16. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
